Sharon Melamed

Ness Ziona, M 74100, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Efficient Identification of Monoclonal Antibodies Against Rift Valley Fever Virus Using High-Throughput Single Lymphocyte Transcriptomics of Immunized Mice.

Efficient Identification of Monoclonal Antibodies Against Rift Valley Fever Virus Using High-Throughput Single Lymphocyte Transcriptomics of Immunized Mice.

Journal: Antibodies (Basel, Switzerland)

Published: December 18, 2024

Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV-ΔG-Spike Vaccine.

Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV-ΔG-Spike Vaccine.

Journal: Vaccines

Published: March 20, 2024

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.

Journal: Science (New York, N.Y.)

Published: November 09, 2023

Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization.

Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization.

Journal: Microbiology spectrum

Published: September 22, 2023

Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection.

Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection.

Journal: Nature communications

Published: September 14, 2023

Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2.

Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2.

Journal: Current issues in molecular biology

Published: August 21, 2023

VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants.

VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants.

Journal: Viruses

Published: May 18, 2023

Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022.

Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: September 02, 2022

Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice.

Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice.

Journal: Viruses

Published: April 26, 2022

Antiviral activity of glucosylceramide synthase inhibitors in alphavirus infection of the central nervous system.

Antiviral activity of glucosylceramide synthase inhibitors in alphavirus infection of the central nervous system.

Journal: Brain communications

Published: March 25, 2022

rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.

rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.

Journal: Archives of toxicology

Published: March 16, 2022

Revisiting SARS-CoV-2 environmental contamination by patients with COVID-19: The Omicron variant does not differ from previous strains.

Revisiting SARS-CoV-2 environmental contamination by patients with COVID-19: The Omicron variant does not differ from previous strains.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: February 20, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026